EPISODE · Dec 11, 2024 · 4 MIN
Phase 3 Results for Novel Sedation Tablet
from Eyewire News: The Podcast · host Eyewire News
New phase 3 data is released for a non-opioid sedation tablet; the first patient is dosed in the phase 3 trial of EyePoint’s wet AMD candidate; and Outlook receives a reimbursement decision in the UK for its wet AMD treatment. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Phase 3 Results for Novel Sedation Tablet
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m